DocGo (DCGO) to Release Quarterly Earnings on Thursday

DocGo (NASDAQ:DCGO) is expected to be issuing its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect DocGo to post earnings of ($0.09) per share for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, March 6, 2026 at 4:00 PM ET.

DocGo Stock Up 0.1%

DCGO opened at $0.74 on Wednesday. The stock has a market capitalization of $72.58 million, a price-to-earnings ratio of -1.43 and a beta of 0.95. DocGo has a twelve month low of $0.66 and a twelve month high of $4.52. The company has a 50-day simple moving average of $0.83 and a 200 day simple moving average of $1.12.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a report on Monday, December 29th. Canaccord Genuity Group lowered their price objective on shares of DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Finally, Zacks Research raised DocGo from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, DocGo presently has an average rating of “Hold” and a consensus price target of $3.21.

Institutional Trading of DocGo

Hedge funds have recently made changes to their positions in the company. Acadian Asset Management LLC acquired a new position in shares of DocGo in the first quarter valued at approximately $338,000. Jane Street Group LLC boosted its position in DocGo by 227.6% during the 2nd quarter. Jane Street Group LLC now owns 279,924 shares of the company’s stock worth $439,000 after buying an additional 194,482 shares during the period. JPMorgan Chase & Co. grew its holdings in DocGo by 16.8% during the 2nd quarter. JPMorgan Chase & Co. now owns 290,354 shares of the company’s stock worth $456,000 after acquiring an additional 41,679 shares during the last quarter. Bridgeway Capital Management LLC increased its position in DocGo by 45.5% in the 4th quarter. Bridgeway Capital Management LLC now owns 539,306 shares of the company’s stock valued at $473,000 after acquiring an additional 168,607 shares during the period. Finally, Geode Capital Management LLC increased its position in DocGo by 3.4% in the 4th quarter. Geode Capital Management LLC now owns 2,259,901 shares of the company’s stock valued at $1,984,000 after acquiring an additional 73,900 shares during the period. 56.44% of the stock is owned by institutional investors and hedge funds.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.